Delivery Order SPE2DB22D1103-SPE2DB25FH3D8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of XDEMVY 0.25% Drop 10ML, a pharmaceutical product. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,223.59 and is scheduled for completion by August 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under a larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,223.59 by the Defense Logistics Agency on August 14, 2025, with an ultimate completion date of September 5, 2025. The delivery order is for XDEMVY 0.25% Drop 10ML and utilizes firm fixed price pricing with no set-aside designation. This award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,223.59 by the Defense Logistics Agency (DLA) on July 22, 2025. The award is for XDEMVY 0.25% Drop 10ML, a pharmaceutical product to be delivered to the Conshohocken, PA location with an ultimate completion date of August 12, 2025. This is a firm fixed price delivery order issued under a non-competitive set-aside arrangement and represents a...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 6, 2025, for pharmaceutical supplies valued at $1,223.59. The contract covers XDEMVY 0.25% DROP 10ML, a specialized pharmaceutical product, with an ultimate completion date of August 27, 2025. The award was made through a competitive process with no set-aside designation and utilizes firm fixed pricing. This delivery order will be fulfilled at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on July 17, 2025, for the supply of XDEMVY 0.25% DROP 10ML, a pharmaceutical product. This is a firm fixed price, non-set-aside contract with an ultimate completion date of August 7, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,223.59 by the Defense Logistics Agency for XDEMVY 0.25% Drop 10ML pharmaceutical product. The contract is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of October 14, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on August 27, 2025, for XDEMVY 0.25% Drop 10ML pharmaceutical product with a ceiling value of $1,223.59. This firm fixed price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, was competitively awarded with no set-aside designation. The place of performance...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% drop in 10ml quantities under a firm fixed price contract. The award was issued on August 28, 2025, with an ultimate completion date of September 19, 2025. This non-competitive delivery order represents a child contract executed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential...
- The Defense Logistics Agency awarded a $1,223.59 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of XDEMVY 0.25% Drop in a 10 mL formulation, with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML pharmaceutical product with a ceiling value of $1,223.59. This firm fixed-price delivery order, issued on September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award is non-competitive with no set-aside designation and...
- SPE2DB22D1103Indefinite Delivery Contract
- SPE2DB22D1103-SPE2DB25FH3D8Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 24, 2025, for the supply of XDEMVY 0.25% DROP 10ML pharmaceutical product. This firm fixed-price delivery order has a ceiling value of $1,223.59 and is scheduled for completion by October 16, 2025. The contract is being performed in Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters, and does not utilize a set-aside designation. As a child contract, this delivery order derives from AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor for military and veteran healthcare systems. The company's DLA contract vehicle supports comprehensive global pharmaceutical supply operations, enabling delivery of specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order represents one transaction within the broader framework of AmerisourceBergen's extensive federal contract portfolio with the DLA Medical Supply Chain, demonstrating the company's capability to fulfill federal medical supply requirements through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 9/24/25 |